Agios Pharmaceuticals
AGIO
#5134
Rank
NZ$3.01 B
Marketcap
NZ$50.37
Share price
-4.03%
Change (1 day)
26.60%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -NZ$0.8 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$98.33 Million. In 2025 the company made an earning of -NZ$0.87 Billion a decrease over its 2024 earnings that were of -NZ$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.8 Billion-7.45%
2025 -NZ$0.87 Billion10.9%
2024 -NZ$0.78 Billion8.75%
2023 -NZ$0.72 Billion0.63%
2022 -NZ$0.72 Billion2.81%
2021 -NZ$0.7 Billion10.58%
2020 -NZ$0.63 Billion-18.41%
2019 -NZ$0.77 Billion15.72%
2018 -NZ$0.67 Billion12.99%
2017 -NZ$0.59 Billion59.61%
2016 -NZ$0.37 Billion69.32%
2015 -NZ$0.22 Billion119.28%
2014 -NZ$98.8 Million39.22%
2013 -NZ$70.97 Million69.1%
2012 -NZ$41.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.71 B-1,618.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.45 B-7,674.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.05 B-1,658.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-NZ$0.22 Billion-74.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.94 B-332.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.69 M-109.51%๐Ÿ‡บ๐Ÿ‡ธ USA